Synata Bio, Inc.

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• MAMatthew AhearnDirector
• MAMichael AhearnDirector · Executive Officer
• MBMary BjorklundExecutive Officer
• AHAlan HendersonDirector
• SKSteven KloosDirector · Executive Officer
• JKJay KoubaDirector
• MMMJ MaloofExecutive Officer
• JPJeremy PattExecutive Officer
• SSSteve SlomaExecutive Officer
• MSMacy StonebackExecutive Officer

• 11 Nov 2025Method Of Dewateringgranted
• 01 May 2025Methods For Efficient Fermention Broth Recycleapplication
• 13 Mar 2025Fermentation Methods Using Acetogenic Carboxydotrophic Bacteriaapplication
• 13 Mar 2025Organisms And Methods Of Use Thereofapplication
• 08 Oct 2024Methods And Systems Using Ionophores To Control Contamination In Fermentation Of Gaseous Substratesgranted
• 04 May 2023Green Methods Of Making Product From Hydrogen Enriched Synthesis Gasapplication
• 28 Jul 2020Methods For Sustaining The Viability Of Microorganisms During A Cessation Of Syngas Flow And Processes For Storage And Reactivation Of Microorganismsgranted
• 25 Jun 2020System And Method For Concentrating Suspended Solids Prior To Removalapplication
• 06 Aug 2019Processes For Controlling The Concentration Of Co-produced Oxygenated Organics In Anaerobic Fermentation Broths For The Bioconversion Of Syngas To Product Oxygenated Organic Compoundgranted
• 02 Jul 2019Processes For Starting Up And Operating Deep Tank Anaerobic Fermentation Reactors For Making Oxygenated Organic Compound From Carbon Monoxide And Hydrogengranted
• 12 Mar 2019Processes And Control Systems For High Efficiency Anaerobic Conversion Of Hydrogren And Carobon Oxides To Alcoholsgranted
• 12 Sept 2017Method For Producing C4 Oxygentates By Fermentation Using High Oxidation State Sulfurgranted

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.